CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79,901 | -30.1% | 19,024 | 0.0% | 0.00% | – |
| Q4 2022 | $114,334 | -38.5% | 19,024 | -40.6% | 0.00% | – |
| Q3 2022 | $186,000 | -5.6% | 32,024 | -3.0% | 0.00% | – |
| Q2 2022 | $197,000 | -10.9% | 33,024 | -30.1% | 0.00% | – |
| Q1 2022 | $221,000 | +88.9% | 47,224 | 0.0% | 0.00% | – |
| Q4 2021 | $117,000 | +1070.0% | 47,224 | +349.8% | 0.00% | – |
| Q1 2019 | $10,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|